Feng Du

3.1k total citations · 2 hit papers
75 papers, 2.2k citations indexed

About

Feng Du is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Feng Du has authored 75 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 24 papers in Cancer Research. Recurrent topics in Feng Du's work include Gastric Cancer Management and Outcomes (15 papers), HER2/EGFR in Cancer Research (14 papers) and Breast Cancer Treatment Studies (14 papers). Feng Du is often cited by papers focused on Gastric Cancer Management and Outcomes (15 papers), HER2/EGFR in Cancer Research (14 papers) and Breast Cancer Treatment Studies (14 papers). Feng Du collaborates with scholars based in China, United States and Ethiopia. Feng Du's co-authors include Jiuda Zhao, Fangchao Zheng, Guoshuang Shen, Dengfeng Ren, Fuxing Zhao, Raees Ahmad, Yongkun Sun, Jinwan Wang, Yihebali Chi and Ziyi Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Feng Du

73 papers receiving 2.2k citations

Hit Papers

Anlotinib: a novel multi-targeting tyrosine kinase inhibi... 2016 2026 2019 2022 2018 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
    2018 446 citations Guoshuang Shen, Fangchao Zheng et al. profile →
  2. Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
    2016 332 citations Yongkun Sun, Feng Du et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Du China 22 1.3k 883 645 503 470 75 2.2k
L. Austin Doyle United States 27 881 0.7× 850 1.0× 1.1k 1.6× 398 0.8× 293 0.6× 71 2.2k
Takeru Wakatsuki Japan 21 1.1k 0.9× 714 0.8× 356 0.6× 319 0.6× 531 1.1× 159 1.8k
Hiroyuki Takahashi Japan 31 879 0.7× 1.3k 1.4× 1.2k 1.8× 555 1.1× 621 1.3× 148 3.3k
Vinod Ganju Australia 24 2.0k 1.5× 906 1.0× 655 1.0× 447 0.9× 323 0.7× 94 2.7k
Yoshiyuki Suehara Japan 23 863 0.7× 1.4k 1.6× 717 1.1× 503 1.0× 269 0.6× 113 2.2k
Alfonso De Stefano Italy 28 964 0.8× 1.0k 1.2× 610 0.9× 501 1.0× 835 1.8× 97 2.5k
Hsuan-Ying Huang Taiwan 30 700 0.6× 822 0.9× 1.2k 1.9× 434 0.9× 429 0.9× 55 2.4k
Yuan‐Tzu Lan Taiwan 30 1.5k 1.2× 833 0.9× 814 1.3× 544 1.1× 680 1.4× 108 2.6k
Caroline E. McCoach United States 18 757 0.6× 1.0k 1.2× 413 0.6× 383 0.8× 290 0.6× 56 1.5k
Iacopo Petrini Italy 27 1.0k 0.8× 723 0.8× 884 1.4× 688 1.4× 220 0.5× 91 2.5k

Countries citing papers authored by Feng Du

Since Specialization
Citations

This map shows the geographic impact of Feng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Du more than expected).

Fields of papers citing papers by Feng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Du. The network helps show where Feng Du may publish in the future.

Co-authorship network of co-authors of Feng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Du. A scholar is included among the top collaborators of Feng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Du. Feng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xia, et al.. (2024). Mulch drip fertigation with diverse tillage practices regulating root bleeding sap, root growth, lodging resistance and improve maize productivity. Agricultural Water Management. 306. 109186–109186. 4 indexed citations
2.
Xie, Si-An, Wen Zhang, Feng Du, et al.. (2024). PTOV1 facilitates colorectal cancer cell proliferation through activating AKT1 signaling pathway. Heliyon. 10(16). e36017–e36017. 3 indexed citations
3.
Wang, Xue, Feng Du, Jian Yue, et al.. (2023). Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer. Cancer Biology and Medicine. 20(2). 155–168. 7 indexed citations
4.
Du, Feng, Xiao Hu, Jing Sun, et al.. (2023). Large cell neuroendocrine carcinoma transformation: A novel acquired drug resistance mechanism in colorectal adenocarcinoma. SHILAP Revista de lepidopterología. 2(2). 159–164. 4 indexed citations
5.
Du, Feng, Songlin Gao, Yiran Si, et al.. (2022). Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer. Breast Cancer Research and Treatment. 194(2). 221–230. 5 indexed citations
6.
Zheng, Fangchao, Feng Du, Haili Qian, et al.. (2021). Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer. Biomarker Research. 9(1). 28–28. 23 indexed citations
7.
Mao, Rui, Yuanchuan Zhang, Feng Du, et al.. (2020). Prognostic Nomogram for Childhood Acute Lymphoblastic Leukemia: A Comprehensive Analysis of 673 Patients. Frontiers in Oncology. 10. 1673–1673. 7 indexed citations
8.
Liu, Hao, Feng Du, Lina Sun, et al.. (2019). GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer. Cell Death and Disease. 10(2). 31 indexed citations
9.
Yuan, Ting, Zhen Ni, Yali Min, et al.. (2019). SOX2 interferes with the function of CDX2 in bile acid-induced gastric intestinal metaplasia. Cancer Cell International. 19(1). 24–24. 32 indexed citations
10.
Chi, Yihebali, Zhiwei Fang, Xiaonan Hong, et al.. (2018). Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma. Clinical Cancer Research. 24(21). 5233–5238. 245 indexed citations
11.
Lei, Chao, Feng Du, Lina Sun, et al.. (2017). miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6. Cell Death and Disease. 8(10). e3101–e3101. 112 indexed citations
12.
Du, Feng, Xiaodi Zhao, & Daiming Fan. (2017). Soft Agar Colony Formation Assay as a Hallmark of Carcinogenesis. BIO-PROTOCOL. 7(12). e2351–e2351. 37 indexed citations
13.
Li, Yiqun, Feng Du, Wenjie Zhu, & Binghe Xu. (2017). Neuroendocrine carcinoma of the breast: a review of 126 cases in China. Chinese Journal of Cancer. 36(1). 45–45. 14 indexed citations
14.
Shen, Guoshuang, Junhui Zhao, Feng Du, et al.. (2016). Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China. World Journal of Gastroenterology. 22(23). 5406–5406. 17 indexed citations
15.
16.
Du, Feng, Peng Yuan, Jiayu Wang, et al.. (2015). Effect of Hormone Therapy on Long-term Outcomes of Patients with Human Epidermal Growth Factor Receptor 2-and Hormone Receptor-Positive Metastatic Breast Cancer: Real World Experience in China. Asian Pacific Journal of Cancer Prevention. 16(3). 903–907. 2 indexed citations
17.
Du, Feng, Susheng Shi, Yongkun Sun, Jinwan Wang, & Yihebali Chi. (2015). Clinicopathological Characteristics and Prognosis of Colorectal Cancer in Chinese Adolescent Patients. Chinese Medical Journal. 128(23). 3149–3152. 6 indexed citations
18.
19.
Du, Feng, et al.. (2013). MORHPOLOGICAL RESPONSES OF SIX PLANT SPECIES TO PATCHY HABITAT WITH DIFFERENT NITROGEN CONCENTRATIONS USING IN-GROWTH CORE METHOD. Polish Journal of Ecology. 61(2). 3 indexed citations
20.
Du, Feng, et al.. (2012). The relationships between aboveground biomass and Voronoi area of coexisting species in an old-field community. Polish Journal of Ecology. 60(3). 479–489. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Austin Doyle Breakdown of academic impact, for papers by Takeru Wakatsuki Breakdown of academic impact, for papers by Hiroyuki Takahashi Breakdown of academic impact, for papers by Vinod Ganju Breakdown of academic impact, for papers by Yoshiyuki Suehara Breakdown of academic impact, for papers by Alfonso De Stefano Breakdown of academic impact, for papers by Hsuan-Ying Huang Breakdown of academic impact, for papers by Yuan‐Tzu Lan Breakdown of academic impact, for papers by Caroline E. McCoach Breakdown of academic impact, for papers by Iacopo Petrini
Rankless by CCL
2026